Department of Otolaryngology-Head and Neck Surgery, Iuliu Hatieganu University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
Department of Molecular Sciences, Iuliu Haţieganu University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Medicina (Kaunas). 2022 Aug 16;58(8):1106. doi: 10.3390/medicina58081106.
: The aim of this study was to investigate the association between smoking status and single-nucleotide polymorphism in candidate genes that had a known association with smoking-related tumors in previous studies and to explore their link to laryngeal cancer risk in a population of northern Romanian descent. The genes selected have key functions in xenobiotic metabolism (GSTs: the glutathione S-transferases family: GSTM1 and GSTT1) and chromosomal management (TERT). : The genotype frequencies of TERT and the GST subfamilies (GSTM1 and GSTT1) were determined using the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique. The relationship between the polymorphisms and the risk of laryngeal cancer was analyzed in a retrospective case-control study of 92 laryngeal cancer cases and 101 controls, all of whom were smokers. : Subjects presenting the GSTT1-null variant had a two-fold increase in risk (OR = 2.05, 95% CI = 1.07-3.95, = 0.02). While no individual risk was observed for the TERT polymorphism, stratification based on gender revealed a nine-fold increase in risk for carriers of the "C" allele in the heterozygote variant who were male (OR = 9, 65% CI = 3.51-26.51, = 0.0000). : The results showed that the GSTT1-null genotype and the mutant heterozygote variant of TERT genes may play a significant role in laryngeal cancer susceptibility in subjects of northern Romanian descent. There may be no association between the susceptibility to laryngeal carcinoma and the GSTM1 polymorphism. The results could not confirm the carcinogenic influence smoking has on laryngeal cancer development for the studied polymorphisms.
: 本研究旨在探讨吸烟状况与候选基因单核苷酸多态性之间的关联,这些候选基因在前瞻性研究中与吸烟相关肿瘤有关,并且在罗马尼亚北部人群中探讨它们与喉癌风险的关系。选择的基因在异生物质代谢(GSTs:谷胱甘肽 S-转移酶家族:GSTM1 和 GSTT1)和染色体管理(TERT)中具有关键功能。 : 使用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术确定 TERT 和 GST 亚家族(GSTM1 和 GSTT1)的基因型频率。在一项回顾性病例对照研究中,对 92 例喉癌病例和 101 例对照进行了多态性与喉癌风险的关系分析,所有这些患者均为吸烟者。 : 携带 GSTT1 缺失变体的个体患癌风险增加了两倍(OR=2.05,95%CI=1.07-3.95, =0.02)。虽然 TERT 多态性没有个体风险,但基于性别的分层分析显示,携带“C”等位基因的杂合变体的男性携带者患癌风险增加了九倍(OR=9,95%CI=3.51-26.51, =0.0000)。 : 结果表明,GSTT1 缺失基因型和 TERT 基因的突变杂合变体可能在罗马尼亚北部人群中发挥重要作用,使个体易患喉癌。GSTM1 多态性与喉癌易感性之间可能没有关联。研究结果不能证实所研究的多态性对吸烟引起的喉癌发展的致癌影响。